NCT01197391View on ClinicalTrials.gov

Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy
Interventions
BIOLOGICAL

REGN728

2 Subcutaneous Cohorts (dose 1, 2)

Trial Locations (2)

Unknown

Miramar

Overland Park

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY